Duine J A
Laboratory of Microbial Biotechnology, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan.
J Biosci Bioeng. 1999;88(3):231-6. doi: 10.1016/s1389-1723(00)80002-x.
About twenty years ago, the cofactor pyrroloquinoline quinone, PQQ, was discovered. Here the author gives his personal view on the reasons why this cofactor was so lately discovered and how the steps in its identification were made. The discovery not only led to subsequent studies on the physiological significance of PQQ but also initiated investigations on other enzymes where the presence of PQQ was expected, resulting in the discovery of three other quinone cofactors, TPQ, TTQ, and LTQ, which differ from PQQ as they are part of the protein chain of the enzyme to which they belong. Enzymes using quinone cofactors, the so-called quinoproteins, copper-quinoproteins, and quinohemoproteins, are mainly involved in the direct oxidation of alcohols, sugars, and amines. Some of the PQQ-containing ones participate in incomplete bacterial oxidation processes like the conversion of ethanol into vinegar and of D-glucose into (5-keto)gluconic acid. Soluble glucose dehydrogenase is the sensor in diagnostic test strips used for glucose determination in blood samples of diabetic patients. Quinohemoprotein alcohol dehydrogenases have an enantiospecificity suited for the kinetic resolution of racemic alcohols to their enantiomerically pure form, certain enantiomers being interesting candidates as building block for synthesis of high-value-added chemicals. Making up for balance after twenty years of quinoprotein research, the following conclusions can be drawn: since quinoproteins do not catalyze unique reactions, we know now that there are more enzymes which catalyze one and the same reaction than we did before, but do not understand the reason for this (compare e.g. NAD/NADP-dependent glucose dehydrogenases, flavoprotein glucose oxidase/dehydrogenase, and soluble/membrane-bound, PQQ-containing glucose dehydrogenases, enzymes all catalyzing the oxidation of beta-D-glucose to delta-gluconolactone but being quite different from each other); however, taking a pragmatic point of view, the foregoing can also be regarded as a positive development since as illustrated by the examples given above, the enlargement of the catalytic arsenal with quinoprotein enzymes provides in more possibilities for enzyme applications; the hopes that PQQ could be a new vitamin have diminished strongly after it has become clear that its occurrence is restricted to bacteria; the impact factor is broader than just the development of the field of quinoproteins, since together with that of enzymes containing a one-electron oxidized amino acid residue as cofactor, it has emphasized that cofactors not only derive from nucleotides (e.g. FAD, NAD) but also from amino acids. Finally, strong indications exist to assume that this is not the end of the story since other quinone cofactors seem awaiting their discovery.
大约二十年前,辅因子吡咯并喹啉醌(PQQ)被发现。在此,作者就该辅因子为何如此晚才被发现以及其鉴定过程中的各个步骤给出了个人观点。这一发现不仅引发了对PQQ生理意义的后续研究,还启动了对其他有望存在PQQ的酶的研究,从而发现了另外三种醌类辅因子,即TPQ、TTQ和LTQ,它们与PQQ不同,因为它们是所属酶蛋白链的一部分。使用醌类辅因子的酶,即所谓的醌蛋白、铜醌蛋白和醌血红蛋白,主要参与醇类、糖类和胺类的直接氧化。一些含PQQ的酶参与细菌的不完全氧化过程,如将乙醇转化为醋以及将D -葡萄糖转化为(5 -酮)葡萄糖酸。可溶性葡萄糖脱氢酶是用于糖尿病患者血样中葡萄糖测定的诊断试纸条中的传感器。醌血红蛋白醇脱氢酶具有对映体特异性,适合将外消旋醇动力学拆分成为对映体纯的形式,某些对映体是合成高附加值化学品的有趣候选物。在醌蛋白研究二十年之后进行总结,可以得出以下结论:由于醌蛋白并不催化独特的反应,我们现在知道催化同一反应的酶比以前更多了,但我们不明白其中的原因(例如比较依赖NAD/NADP的葡萄糖脱氢酶、黄素蛋白葡萄糖氧化酶/脱氢酶以及可溶性/膜结合的含PQQ的葡萄糖脱氢酶,这些酶都催化β - D -葡萄糖氧化为δ -葡萄糖酸内酯,但彼此差异很大);然而,从务实的角度来看,上述情况也可被视为一种积极的发展,因为如上述例子所示,醌蛋白酶催化武器库的扩充为酶的应用提供了更多可能性;在明确PQQ的存在仅限于细菌之后,认为它可能是一种新维生素的希望已大幅降低;其影响范围不仅限于醌蛋白领域的发展,因为与含有单电子氧化氨基酸残基作为辅因子的酶一起,它强调了辅因子不仅来源于核苷酸(如FAD、NAD),还来源于氨基酸。最后,有强烈迹象表明这并非故事的终结,因为似乎还有其他醌类辅因子有待发现。